This site is intended for healthcare professionals
A simple blood test can detect the risk of osteoporosis
An electrode array-based device incorporating recombinase polymerase and electrochemical detection of osteoporosis-linked single nucleotide polymorphisms could help identify the risk of osteoporosis in just 15 minutes. However, it might not diagnose osteoporosis. This versatile technology was previously used to detect drug resistance in treating tuberculosis.
A saliva test can help decide the treatment path for obese patients
Not all anti-obesity medications are effective for all patients, as per experts. Patients' DNA, biomarkers, and behavioural assessments determine the phenotype of obesity and the right choice of treatment. Phenomix's My Phenome Hungry Gut test used saliva samples of patients to determine the phenotype, and they will be given Wegovy or Ozempic based on the test results.
A test to identify pregnancy-related complications receives FDA approval
Thermo Fisher Scientific Inc's biomarker test can help identify women at an increased risk of severe preeclampsia. It is the first-of-its-kind test, which can help reduce mortality from the leading cause during pregnancy in women across the world. This test will have a remarkable impact on the prognosis and treatment of women during pregnancy and postpartum.
WHO warns against misinformation on using AI in healthcare
It advised clinicians to be aware that data used by artificial intelligence in healthcare settings could be inaccurate, misused, and biased. It can lead to the generation of disinformation. It is critical to evaluate the risks of using tools like ChatGPT to protect public health. But, it is also enthusiastic about AI's potential in improving decision-making and diagnosis.
What are the four signs you might have colon cancer?
Researchers found that abdominal pain, diarrhoea, rectal bleeding, and iron deficiency anemia are the four red flag symptoms that indicate colon cancer in people aged below 50 years. Having one of these symptoms almost doubled the risk of cancer, while having two of them tripled the risk. Researchers advise younger adults to know these signs for early detection and treatment.
Gut microbiome of a person can help plan heart failure treatment
Research suggests that heart failure pathophysiology is modulated by the gut microbiome. It can also contribute to disease progression and treatment responses, making it a novel biomarker. These interactions with diet, gut microbiome, and medications can help develop innovative and interdisciplinary management strategies for patients with heart failure.
A test can help monitor disease progression in colorectal cancer
Researchers analysed circulating tumor DNA methylation in patients with CRC. They found that ctDNA's presence was strongly linked to cancer recurrence before and after adjuvant chemotherapy and surgery and during longitudinal monitoring. This tool is effective in helping risk stratification, residual disease detection, relapse surveillance, and chemotherapy guidance.
New Parkinson's test could help in the early detection
The new test is an alpha-synuclein seeding amplification assay that can detect the abnormal protein in patients with Parkinson's disease in asymptomatic and symptomatic individuals. The test confirmed the presence of protein in most people with an accuracy of 93%. This test could have an added benefit to newly diagnosed patients to prevent fully-blown symptoms.
Updated guidance on the alpha-gal syndrome to help GI clinicians
The guidance highlights that patients with alpha-gal allergy experience gastrointestinal symptoms like vomiting, nausea, diarrhoea abdominal pain without anaphylaxis or skin changes. It can be diagnosed if patients have GI distress and elevated igE, and the GI symptoms relieve with an alpha-gal avoidance diet. Diet assistance should be given as primary management.
What are the common allegations against nurse practitioners?
A study analyzed claims against NPs working in internal medicine and family medicine from 2011 to 2016. The top claims in the allegations included diagnosis-related, medication-related, and medical treatment-related issues. Diagnosis-related claims accounted for 41%, with myocardial infarction, colon cancer, breast cancer, lung cancer, and pneumonia as the top 5 allegations.
The Doctors Company